EQ · Equillium Inc
United States · RS rating 17 · As of 2026-10-14
| Price | 1.30 USD |
|---|---|
| 1-day change | -1.5% |
| RS rating (overall / 1M / 3M / 12M) | 17 / 4 / 5 / 48 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 31 / 29 / 47 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +33.3% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +59.4% |
| Market cap (USD) | $137.2M |